Menu

ASX Announcements

HomeInvestors CentreASX Announcements

Name Last Modified
Name Last Modified
New TALi Digital Board Update
29-06-2020
New Positive Study Results for DETECT Product
23-06-2020
Duke University and TALi Agreement
22-06-2020
TALi Research Projects Update
22-06-2020
Live Virtual Conference Presentation
30-04-2020
Investor Presentation
30-04-2020
Company Update & Appendix 4C Quarter Ended 31 March 2020
30-04-2020
U.S. patent further strengthens TALi Digital Platform
21-04-2020
Updated Announcement: China Trademark for TALi
01-04-2020
Appendix 3Y Change of Director’s Interest Notice
26-03-2020
TALi DETECT assessment yields positive results
25-03-2020
Strong cash position drives marketing initiatives and key appointments
24-03-2020
Appendix 4D
20-02-2020
Company Update & Appendix 4C Quarter Ended 31 December 2019
19-02-2020
Google For Education Partner certification achieved
14-01-2020
Change of Company Name and ASX Code
22-12-2019
Appendix 3B
03-12-2019
Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)
03-12-2019
Annual Report 2019
01-12-2019
AGM Presentation November 2019
25-11-2019
Annual General Meeting Chairman’s Address
25-11-2019
2019 Annual General Meeting Results
25-11-2019
Novita conducts successful $6.2m placement
24-11-2019
Novita Healthcare Ltd (ASX: NHL) – Trading Halt
20-11-2019
Response to Aware Query
15-11-2019
National Disability Insurance Scheme (NDIS) Expands Access to TALi
11-11-2019
Managing Director Video Interview
31-10-2019
Company Update & Appendix 4C Quarter Ended 30 September 2019
31-10-2019
U.S. Reimbursement Codes for TALi Train
31-10-2019
Corporate Governance Statement
31-10-2019
Appendix 4G
25-10-2019
Notice Of Meeting And Explanatory Statement
25-10-2019
Updated Announcement: US Reimbursement Codes for TALI Train
12-10-2019
Managing Director Video Interview
23-09-2019
Completion of $2M Entitlement Offer And Shortfall Placement
20-09-2019
Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)
20-09-2019
Appendix 3B
20-09-2019
Novita Signs Key UK Partner Supply Agreement
17-09-2019
Appendix 3B
16-09-2019
Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)
16-09-2019
Update on Entitlement Offer
16-09-2019
Shortfall Placement Update
05-09-2019
Change of Director’s Interest Notice
05-09-2019
Change of Director’s Interest Notice
05-09-2019
Appendix 3B
05-09-2019
Change of Director’s Interest Notice
05-09-2019
Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)
05-09-2019
Change of Director’s Interest Notice
02-09-2019
Successful Shortfall Placement
30-08-2019
TALi TRAIN Receives CE Mark
30-08-2019
Appendix 4E
30-08-2019
Completion of Entitlement Offer
27-08-2019
Entitlement Offer Booklet
15-08-2019
Entitlement Offer - Notification to Ineligible Shareholders
15-08-2019
Appendix 3B
07-08-2019
Cleansing Notice under section 708AA(2)(f) of the Corporations Act 2001 (Cth)
07-08-2019
Entitlement Offer - Information for Optionholders
07-08-2019
Entitlement Offer - Information for Shareholders
07-08-2019
Entitlement Offer To Raise Up to $2 Million
07-08-2019
Appendix 4C Quarter Ended 30 June 2019
01-08-2019
Non-Deal Roadshow Presentation
30-07-2019
Novita's TALi DETECT to be used to Assess Attention Deficit Issues in Victorian Public School Children
09-07-2019
Response to Appendix 4C
07-05-2019
Change of Director’s Interest Notice
06-05-2019
First USA school district commences with Tali
06-05-2019
Change of Director’s Interest Notice
06-05-2019
Change of Director’s Interest Notice
06-05-2019
Appendix 4D Half Year Result
06-05-2019
Change of Company Secretary
06-05-2019
Novita To Present at Global Digital Therapeutics Conference
06-05-2019
Novita Partnership with US based Paediatric Care Management Platform to Drive Growth
06-05-2019
Largest Public School District in Oregon USA to Commence with Novita
06-05-2019
NOVITA HEALTHCARE LIMITED – CHANGE OF ADDRESS
04-01-2019
Change of Director’s Interest Notice
04-01-2019
Change of Director's Interest Notice
13-12-2018
Chairs Address and Managing Directors Presentation
29-11-2018
Results of Meeting
29-11-2018
Corporate Governance Statement
10-11-2018
Change of Director's Interest Notice
30-10-2018
Appendix 4C - Quarterly
30-10-2018
Change of Director's Interest Notice
26-10-2018
Newly Sale and Healthcarelink Investment Completion
18-10-2018
Notice of Annual General Meeting
17-10-2018
Change in Substantial Holding
16-10-2018
Amended 2018 Annual Report to shareholders
12-10-2018
Annual Report to shareholders (Released)
12-10-2018
Notice of Annual General Meeting/Proxy Form
12-10-2018
Change of Director's Interest Notice
11-10-2018
Change of Director's Interest Notice
09-10-2018
Appendix 3B
09-10-2018
Change of Director's Interest Notice
25-09-2018
Date of AGM
17-09-2018
FDA lists TALI Train
10-09-2018
NOVITA HEALTHCARE STRENGTHENS BOARD FOR GROWTH SUE MACLEMAN
06-09-2018
Annual Report to shareholders
04-09-2018
Change in substantial holding
03-09-2018
Appendix 4G - Corporate Governance Disclosure
31-08-2018
Full Year Statutory Accounts
31-08-2018
Appendix 4C - quarterly
31-07-2018
Change in substantial holding
27-07-2018
Appendix 3B, Cleansing Notice & Additional Information
21-07-2018
Successful $2.78 mil. Placement completed
21-07-2018
Company Presentation
20-07-2018
Reinstatement to Official Quotation
20-07-2018
Suspension from Official Quotation
20-07-2018
Trading Halt
17-07-2018
TALI TRAIN ON REGISTER OF THERAPEUTIC GOODS
28-05-2018
TALI HEALTH NATIONAL DISABILITY INSURANCE SCHEME (NDIS) APPROVAL
17-05-2018
Final Director's Interest Notice
11-05-2018
Initial Director's Interest Notice
11-05-2018
Board Restructure
10-05-2018
Becoming and Ceasing substantial holder - 9 May 18
09-05-2018
COMPANY UPDATE & APPENDIX 4C QUARTER ENDED 31 MARCH 2018
01-05-2018
TALI HEALTH PROGRESS UPDATE
19-04-2018
Half Year Company Presentation
28-02-2018
COMPANY UPDATE & APPENDIX 4D COMMENTARY HALF YEAR ENDED 31 DEC 2017
28-02-2018
Appendix 4C Quarterly
01-02-2018
Change in Substantial Holding DAK
18-01-2018
Novita Healthcare Company Presentation 2017
14-12-2017
Novita Healthcare Awarded A $1.2M Grant
06-12-2017
Appendix 3B - Directors Options
23-11-2017
Change of Director's Interest Notices - 3 Directors
23-11-2017
Results of Meeting AGM
30-10-2017
Chairman's Address to Shareholders
30-10-2017
Appendix 4C September 2017 Quarterly
30-10-2017
Novita Appoints New Chief Executive Officer
03-10-2017
Appendix 3B
03-10-2017
Notice of Annual General Meeting Proxy Form
28-09-2017
Becoming a Substantial Holder
20-09-2017
Initial Director's Interest Notice
20-09-2017
Director Appointment
15-09-2017
Change of Director's Interest Notice - Mr Harcourt
14-09-2017
Novita Healthcare Limited Annual Report 2017 v2
11-09-2017
Changed Date of 2017 AGM
31-08-2017
Appendix 4E Including Final Financial Report 2017
29-08-2017
Appendix 4G
29-08-2017
Appendix 3B & Cleansing Notice
28-08-2017
Appendix 3Y for Three Directors
28-08-2017
Rights Issue Success and Shortfall Notification
23-08-2017
Appendix 3B and Cleansing Notice
22-08-2017
Results of Meeting EGM
18-08-2017
Results of EGM
18-08-2017
Company Update & Appendix 4C Quarterly
08-08-2017
Newly Acquisition Completed
21-07-2017
Notice of Extraordinary General Meeting Proxy Form
19-07-2017
Appendix 3B
14-07-2017
Letter to Shareholders re Rights Issue
13-07-2017
Non-Renounceable Issue Offer Document
13-07-2017
Acquisition and Capital Raising
12-07-2017
Capital Raising Presentation
12-07-2017
Non-Renounceable Issue Cleaning Notice & Appendix 3B
12-07-2017
Company Update
03-07-2017
Change of Address
31-03-2017
Half Yearly Report & Accounts
24-02-2017
Company Update & Appendix 4C
30-01-2017
Results of AGM
29-12-2016
Unmarketable Parcel Share Sale Facility Closed
14-12-2016
Share Sale Facility
14-12-2016
Change of Company Name
08-12-2016
Chairmans Presentation to Shareholders
29-11-2016
Final Directors Interest Notice - Mr Tan Retires
29-11-2016
Notice of Annual General Meeting
25-11-2016
Corporate Governance Statement & Appendix 4G
28-10-2016
Notice of Annual General Meeting Proxy Form
28-10-2016
Appendix 4C Quarterly
28-10-2016
Annual Report to Shareholders 2016
28-10-2016
Unmarketable Parcel Share Sale Facility & Form
25-10-2016
AVX_2016-10-21_Change-of-Registry
21-10-2016
AVX_2016-10-10_Company-Secretary-Appointment-Resignation
10-10-2016
AVX_2016-09-02_Change-of-Directors-Interest-Notice_Iain-Kirkwood
02-09-2016
AVX_2016-09-02_Change-of-Directors-Interest-Notice_Jefferson-Harcourt
02-09-2016
AVX_2016-09-01_Initial-Directors-Interest-Notice_Mark-Simari
01-09-2016
AVX_2016-09-01_Non-Executive-Director-Appointment_Mark-Simari
01-09-2016
AVX_2016-08-30_Full-Year-Statutory-Accounts
30-08-2016
AVX_2016-08-30_Preliminary-Final-Report
30-08-2016
AVX_2016-08-29_Rights-Issue-Allotment-Appendix-3B-Cleansing-Notice
29-08-2016
AVX_2016-08-26_Rights-Issue-Closed-Avexa-Raises-2.2-Million
26-08-2016
AVX_2016-08-09_Rights-Issue-Dispatch-of-Offer-Booklet
09-08-2016
AVX_2016-08-02_Final-Directors-Interest-Notice
02-08-2016
AVX_2016-08-02_Rights-Issue-Letter-to-Shareholders
02-08-2016
AVX_2016-07-29_Cleansing-Notice-and-Appendix-3B
29-07-2016
AVX_2016-07-29_Rights-Issue-Offer-Document
29-07-2016
AVX_2016-07-29_Appendix-4C-Quarterly
29-07-2016
AVX_2016-07-27_Capital-Raising-Presentation
27-07-2016
AVX_2016-07-27_Rights-Issue-Announcement
27-07-2016
AVX_2016-07-25_Trading-Halt
25-07-2016
AVX_2016-07-19_Final-Directors-Interest-Notice_Bruce-Hewett
19-07-2016
AVX_2016-07-12_Director-Resignation_Bruce-Hewett
12-07-2016
AVX_2016-07-08_Change-of-Directors-Interest-Notice
08-07-2016
AVX_2016-06-28_Change-of-Directors-Interest-Notice_Iain-Kirkwood
28-06-2016
AVX_2016-06-16_Company-Update
16-06-2016
AVX_2016-06-09_Interview-with-Open-Briefing
09-06-2016
AVX_2016-06-06_Change-of-Directors-Interest-Notice_Benjamin-Yeo
06-06-2016